Stocks Surge Midday: Accenture Soars 18%, Synopsys Rises Over 8%, United Therapeutics Jumps 6% Following Court Ruling

Accenture's stock surged 18% after reporting fiscal fourth-quarter revenue of $18.7 billion, surpassing both its guidance and analyst expectations. McCormick's adjusted earnings of 86 cents per share exceeded forecasts, yet its stock fell over 2% amid an ongoing acquisition by Unilever.

McKesson's shares rose 4% after reaffirming its fiscal 2027 earnings guidance and extending a partnership with CVS Health. A federal court ruling favored United Therapeutics, leading to a 6% increase in its shares, while Liquidia's stock dropped 15% due to the ruling's negative implications for its lung treatment.

Constellation Energy's shares climbed nearly 3% following a long-term deal with Amazon, and Synopsys shares jumped over 8% after outlining a growth strategy and announcing a partnership with OpenAI. Sigma Lithium's shares fell 16% after suspending production due to legal delays, while Acuity Brands saw a nearly 4% drop after providing lower-than-expected sales growth guidance.

BJ's Restaurants' stock rose about 5% following an upgrade from Mizuho, and Vicor's shares surged almost 10% after raising its revenue growth forecast. Corteva's spinoff of its Vylor business resulted in an 84% plunge for the remaining company shares after a court ruling allowed the separation to proceed

Stocks in this article

Company Price Change Change % AI
McKesson Corporation MCK.US 1,102.81 +25.76 +2.39% Buy
Synopsys SNPS.US 455.20 -7.49 -1.62% Buy
BJ's Restaurants BJRI.US 55.77 +0.88 +1.60% Hold
Liquidia LQDA.US 57.41 -0.71 -1.22% Buy
Constellation Energy CEG.US 280.20 -2.20 -0.78% Buy
CVS Health CVS.US 89.35 -0.44 -0.49% Hold
United Therapeutics UTHR.US 591.17 -2.14 -0.36% Buy
Amazon AMZN.US 266.66 -0.78 -0.29% Buy
Accenture ACN.US 250.49 +0.54 +0.22% Buy
Acuity Brands AYI.US 330.53 +0.25 +0.08% Buy

StockGuide AI model context

Amazon · Buy · Risk: 42/100 · Potential: 70/100 · 2026-11-14

Acuity Brands · Buy · Risk: 39/100 · Potential: 70/100 · 2026-11-14

BJ's Restaurants · Hold · Risk: 54/100 · Potential: 59/100 · 2026-11-14

Liquidia · Buy · Risk: 40/100 · Potential: 72/100 · 2026-11-14

United Therapeutics · Buy · Risk: 38/100 · Potential: 71/100 · 2026-11-14

More business news